Preoperative serum interleukin-6 is a potential prognostic factor for colorectal cancer, including stage II patients

Gastroenterology Research and Practice

Volumn 2016, Issue , 2016, Pages

  Shiga, Kazuyoshi ^a   Hara, Masayasu ^a   Nagasaki, Takaya ^a   Sato, Takafumi ^a   Takahashi, Hiroki ^a   Sato, Mikinori ^a   Takeyama, Hiromitsu ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; INTERLEUKIN 6;

AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE PERIOD;

EID: 84956953307     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2016/9701574     Document Type: Article

References (31)

1. C. E. Dukes, "The classification of cancer of the rectum, " The Journal of Pathology and Bacteriology, vol. 35, no. 3, pp. 323-332, 1932.
2. M. P. Nowacki, P. Janik, and P. M. Nowacki, "Inflammation and metastases, " MedicalHypotheses, vol. 47, no. 3, pp. 193-196, 1996.
3. F. Pages, J. Galon, M.-C. Dieu-Nosjean, E. Tartour, C. Sautes-Fridman, and W.-H. Fridman, "Immune infiltration in human tumors: a prognostic factor that should not be ignored, " Oncogene, vol. 29, no. 8, pp. 1093-1102, 2010.
4. D. C. McMillan, K. Canna, and C. S. McArdle, "Systemic inflammatory response predicts survival following curative resection of colorectal cancer, " British Journal of Surgery, vol. 90, no. 2, pp. 215-219, 2003.
5. R. Sharma, M. Zucknick, R. London, M. Kacevska, C. Liddle, and S. J. Clarke, "Systemic inflammatory response predicts prognosis in patients with advanced-stage colorectal cancer, " Clinical Colorectal Cancer, vol. 7, no. 5, pp. 331-337, 2008.
6. D. C. McMillan, J. E. M. Crozier, K. Canna, W. J. Angerson, and C. S. McArdle, "Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer, " International Journal of Colorectal Disease, vol. 22, no. 8, pp. 881-886, 2007.
7. C. W. Wu, S. R. Wang, M. F. Chao, et al., "Serum interleukin-levels reflect disease status of gastric cancer, " The American Journal of Gastroenterology, vol. 91, no. 7, pp. 1417-1422, 1996.
8. M. Lukaszewicz-Zajac, B. Mroczko, M. Gryko, B. Kedra, and M. Szmitkowski, "Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer, " Clinical and Experimental Medicine, vol. 11, no. 2, pp. 89-96, 2011.
9. M. Oka, K. Yamamoto, M. Takahashi, et al., "Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma, " Cancer Research, vol. 56, no. 12, pp. 2776-2780, 1996.
10. H. Yanagawa, S. Sone, Y. Takahashi, et al., "Serum levels of interleukin 6 in patients with lung cancer, " British Journal of Cancer, vol. 71, no. 5, pp. 1095-1098, 1995.
11. J. Nakashima, M. Tachibana, Y. Horiguchi, et al., "Serum interleukin 6 as a prognostic factor in patients with prostate cancer, " Clinical Cancer Research, vol. 6, no. 7, pp. 2702-2706, 2000.
12. G.-J. Zhang and I. Adachi, "Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma, " Anticancer Research, vol. 19, no. 2, pp. 1427-1432, 1999.
13. Y. Kanda, "Investigation of the freely available easy-to-use software EZR for medical statistics, " BoneMarrowTransplantation, vol. 48, no. 3, pp. 452-458, 2013.
14. C. Belluco, D. Nitti, M. Frantz, et al., "Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer, " Annals of Surgical Oncology, vol. 7, no. 2, pp. 133-138, 2000.
15. B. H. Al-Ghurabi, "The role of serum IL-6 in colorectal cancer patients and its relationship with serum CEA level, " Journal of the Faculty of Medicine, vol. 51, no. 4, pp. 403-406, 2009.
16. D. Mazhar and S. Ngan, "C-reactive protein and colorectal cancer, " QJM, vol. 99, no. 8, pp. 555-559, 2006.
17. T. Nozoe, T. Matsumata, M. Kitamura, and K. Sugimachi, "Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer, " The American Journal of Surgery, vol. 176, no. 4, pp. 335-338, 1998.
18. B. M. Buchholz, R. S. Chanthaphavong, T. R. Billiar, and A. J. Bauer, "Role of interleukin-6 in hemopoietic and nonhemopoietic synergy mediating TLR4-triggered late murine ileus and endotoxic shock, " Neurogastroenterology andMotility, vol. 24, no. 7, pp. e658-e294, 2012.
19. X.-Z. Shi and S. K. Sarna, "Transcriptional regulation of inflammatory mediators secreted by human colonic circular smooth muscle cells, " American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 289, no. 2, pp. G274-G284, 2005.
20. K. H. Edmiston, A. Gangopadhyay, Y. Shoji, A. P. Nachman, P. Thomas, and J. M. Jessup, "In vivo induction ofmurine cytokine production by carcinoembryonic antigen, " Cancer Research, vol. 57, no. 19, pp. 4432-4436, 1997.
21. A. Gangopadhyay, O. Bajenova, T. M. Kelly, and P. Thomas, "Carcinoembryonic antigen induces cytokine expression in Kuppfer cells: implications for hepatic metastasis from colorectal cancer, " Cancer Research, vol. 56, no. 20, pp. 4805-4810, 1996.
22. C. Giessen, D. Nagel, M. Glas, et al., "Evaluation of preoperative serum markers for individual patient prognosis in stage I-III rectal cancer, " Tumour Biology, vol. 35, no. 10, pp. 10237-10248, 2014.
23. Y. Huang, J. S. Liu, and J. F. Feng, "The combination of preoperative serumC-reactive protein and carcinoembryonic antigen is a useful prognostic factor inpatientswith esophageal squamous cell carcinoma: a combined ROC analysis, " OncoTargets and therapy, vol. 8, pp. 795-803, 2015.
24. K. A. Kwon, S. H. Kim, S. Y. Oh, et al., "Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer, " BMC Cancer, vol. 10, article 203, 2010.
25. T. Hashimoto, M. Itabashi, S. Ogawa, et al., "Sub-classification of Stage II colorectal cancer based on clinicopathological risk factors for recurrence, " Surgery Today, vol. 44, no. 5, pp. 902-905, 2014.
26. B. Cakar, U. Varol, B. Junushova, et al., "Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer, " Journal of BUON, vol. 18, no. 2, pp. 372-376, 2013.
27. S. Hatano, H. Ishida, K. Ishibashi, K. Kumamoto, N. Haga, and I. Miura, "Identification of risk factors for recurrence in highrisk stage II colon cancer, " International Surgery, vol. 98, no. 2, pp. 114-121, 2013.
28. T. Kinoshita, H. Ito, and C. Miki, "Serum interleukin-6 level reflects the tumor proliferative activity in patients with colorectal carcinoma, " Cancer, vol. 85, no. 12, pp. 2526-2531, 1999.
29. Y.-C. Chung and Y.-F. Chang, "Serum interleukin-6 levels reflect the disease status of colorectal cancer, " Journal of Surgical Oncology, vol. 83, no. 4, pp. 222-226, 2003.
30. K.-Y. Yeh, Y.-Y. Li, L.-L. Hsieh, et al., "Analysis of the effect of serum interleukin-6 (IL-6) and soluble IL-6 receptor levels on survival of patients with colorectal cancer, " Japanese Journal of Clinical Oncology, vol. 40, no. 6, Article IDhyq010, pp. 580-587, 2010.
31. Y.-C. Chung, Y.-L. Chaen, and C.-P. Hsu, "Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma, " Anticancer Research, vol. 26, no. 5, pp. 3905-3911, 2006.